Astrazeneca Pharma India Ltd: Stock Analysis & Fundamentals

Updated this week

Astrazeneca Pharma India Ltd (Pharma - MNC bulk Drugs) — fundamental analysis, earnings data, and key metrics. PE: 95.3. ROE: 23.6%. This stock is not currently in the Nifty 500 momentum outperformers list.

Key Numbers

Current Price

₹7,931

Dividend Yield

0.40%

Market Cap

19.8K Cr

Valuation

N/A

Other Top Pharma - MNC bulk Drugs Stocks Beating Nifty 500

Novartis India Ltd

Weak • 6w streak

+36.4%

← Back to Pharma - MNC bulk Drugs Dashboard

Frequently Asked Questions: Astrazeneca Pharma India Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Astrazeneca Pharma India Ltd's latest quarterly results?

Astrazeneca Pharma India Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: +6.5%
Revenue Growth YoY: +39.1%
Operating Margin: 7.0%

What is Astrazeneca Pharma India Ltd's current PE ratio?

Astrazeneca Pharma India Ltd's current PE ratio is 95.3x.

Current PE: 95.3x
Market Cap: 19.8K Cr
Dividend Yield: 0.40%

What is Astrazeneca Pharma India Ltd's price-to-book ratio?

Astrazeneca Pharma India Ltd's price-to-book ratio is 24.8x.

Price-to-Book (P/B): 24.8x
Book Value per Share: ₹320
Current Price: ₹7931

Is Astrazeneca Pharma India Ltd a fundamentally strong company?

Astrazeneca Pharma India Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 33.0%

Is Astrazeneca Pharma India Ltd debt free?

Astrazeneca Pharma India Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹35 Cr

What is Astrazeneca Pharma India Ltd's return on equity (ROE) and ROCE?

Astrazeneca Pharma India Ltd's return ratios over recent years

FY2023: ROCE 31.0%
FY2024: ROCE 31.0%
FY2025: ROCE 33.0%

Is Astrazeneca Pharma India Ltd's cash flow positive?

Astrazeneca Pharma India Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹65 Cr
Free Cash Flow (FCF): ₹96 Cr
CFO/PAT Ratio: 56% (adequate)

What is Astrazeneca Pharma India Ltd's dividend yield?

Astrazeneca Pharma India Ltd's current dividend yield is 0.40%.

Dividend Yield: 0.40%
Current Price: ₹7931

Who holds Astrazeneca Pharma India Ltd shares — promoters, FII, DII?

Astrazeneca Pharma India Ltd's shareholding pattern (Dec 2025)

Promoters: 75.0%
FII (Foreign): 2.7%
DII (Domestic): 5.5%
Public: 16.7%

Is promoter holding increasing or decreasing in Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 75.0% (Dec 2025)
Previous Quarter: 75.0% (Sep 2025)
Change: 0.00% (stable)

Is Astrazeneca Pharma India Ltd a new momentum entry or an established outperformer?

Astrazeneca Pharma India Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Astrazeneca Pharma India Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Astrazeneca Pharma India Ltd may be worth studying

Cash flow is positive — CFO ₹65 Cr

What is the investment thesis for Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd investment thesis summary:

What is the future outlook for Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.